United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Nano-X Imaging Ltd.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -27.83% | -5.18% | -5.57% | -6.91% | -8.02% | -10.05% |
|---|---|---|---|---|---|---|
| ROA | -24.97% | -4.4% | -4.21% | -4.6% | -4.65% | -4.98% |
| Gross Margin | -94.03% | 15% | 15% | 15% | 15% | 9.86% |
| Net Margin | -474.31% | -75.94% | -71.12% | -74.41% | -74.66% | -79.49% |
| Total Assets | $210,002.00K | $223,687.70K | $238,471.24K | $254,440.75K | $271,675.44K | $290,255.66K |
| Net Income | -$53,516.00K | -$9,547.97K | -$9,735.54K | -$11,345.38K | -$12,226.67K | -$13,997.67K |